Tatva Chintan Pharma Chem Limited which had tapped the capital markets with its fresh offer for Rs 225 crs and an offer for sale of Rs 275 crs listed on the bourses and recorded a spectacular performance. Shares listed at Rs 2,111.80 on BSE and at Rs 2,111.85 on NSE. The traded volume at the discovered price was 62,390 shares at BSE and 6,45,663 shares on NSE.

The price band of the issue was Rs 1,073-1,083. The issue had opened on Friday the 16th of July and closed on Tuesday the 20th of July. It had received overwhelming support and was subscribed 182.04 times. The QIB portion was subscribed 186.96 times, HNI portion was subscribed 516.99 times and Retail portion was subscribed 35.68 times. The issue garnered 32.44 lac applications and this is a new record by itself. This incidentally beats the number of applications that an issue which was almost 15 times bigger in size, Zomato, received a slightly higher number of applications. On the basis of number of applications, the issue was subscribed 26.10 times.

Earlier the company had completed allocation to anchor investors by allotting 13,85,040 shares amongst 15 anchor investors equally. These anchor investors consisted of 22 entities. There were 7 domestic funds in the total allocation. The allocation is 6.67% or 92,339 shares rounded off to make 100% of the anchor.

The high of the day on BSE was Rs 2,486.30, the low was the opening price of Rs 2,111.80 and the close was Rs 2,310.25. The gain was Rs 1,227.25 or 113.32%. On NSE, the high of the day was Rs 2,534.20, low was the open of the day of Rs 2,111.85 and the close was Rs 2,312.20 a gain of Rs 1,229.20 or 113.50%.